AI English summary of an SEC filing — figures as filed
CVS Health CVSCVS Health said at its May 15, 2025 annual meeting of stockholders, 13 director nominees were elected to the Board of Directors for a term of 1 year. The company said holders of 1,125,353,195 shares of its common stock attended the meeting in person or by valid proxy, constituting a quorum.
Key points
AI summaryCVS Health said at its May 15, 2025 annual meeting of stockholders, 13 director nominees were elected to the Board of Directors for a term of 1 year. The company said holders of 1,125,353,195 shares of its common stock attended the meeting in person or by valid proxy, constituting a quorum.
CVS Health said the election of Fernando Aguirre as a director received 988,213,560 votes for, 24,323,188 against, 1,486,503 abstentions and 111,329,944 broker non-votes.
CVS Health said stockholders approved the appointment of Ernst & Young LLP as its independent registered public accounting firm for 2025, with 1,104,541,067 votes for and 19,205,277 against. The advisory vote on executive compensation was also approved, with 597,945,237 votes for and 413,324,138 against.
CVS Health said a stockholder proposal to lower the threshold for stockholders to act by written consent was not approved, with 431,195,972 votes for and 577,886,190 against.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Election of 13 directors at May 15, 2025 annual stockholder meeting
CVS Health said at its May 15, 2025 annual meeting of stockholders, 13 director nominees were elected to the Board of Directors for a term of 1 year. The company said holders of 1,125,353,195 shares of its common stock attended the meeting in person or by valid proxy, constituting a quorum.
Source · Based on the filing body and exhibits
Vote on Fernando Aguirre's election as director
CVS Health said the election of Fernando Aguirre as a director received 988,213,560 votes for, 24,323,188 against, 1,486,503 abstentions and 111,329,944 broker non-votes.
Source · Based on the filing body and exhibits
Ernst & Young ratification and executive pay advisory vote approved
CVS Health said stockholders approved the appointment of Ernst & Young LLP as its independent registered public accounting firm for 2025, with 1,104,541,067 votes for and 19,205,277 against. The advisory vote on executive compensation was also approved, with 597,945,237 votes for and 413,324,138 against.
Source · Based on the filing body and exhibits
Stockholder proposal to ease written consent threshold fails
CVS Health said a stockholder proposal to lower the threshold for stockholders to act by written consent was not approved, with 431,195,972 votes for and 577,886,190 against.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…